Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Relay Therapeutics (RLAY) Times Interest Earned (2020 - 2023)

Relay Therapeutics (RLAY) has disclosed Times Interest Earned for 4 consecutive years, with -$33725.7 as the latest value for Q1 2023.

  • Quarterly Times Interest Earned fell 1029.19% to -$33725.7 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was -$124333.3 through Dec 2023, down 772.44% year-over-year, with the annual reading at -$91174.5 for FY2021, 2514.51% down from the prior year.
  • Times Interest Earned for Q1 2023 was -$33725.7 at Relay Therapeutics, down from -$2986.7 in the prior quarter.
  • The five-year high for Times Interest Earned was $4373.5 in Q4 2020, with the low at -$33725.7 in Q1 2023.
  • Average Times Interest Earned over 4 years is -$9563.5, with a median of -$7901.2 recorded in 2020.
  • The sharpest move saw Times Interest Earned skyrocketed 64.78% in 2022, then plummeted 1029.19% in 2023.
  • Over 4 years, Times Interest Earned stood at $4373.5 in 2020, then plummeted by 293.92% to -$8481.0 in 2021, then surged by 64.78% to -$2986.7 in 2022, then tumbled by 1029.19% to -$33725.7 in 2023.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$33725.7, -$2986.7, and -$8481.0 for Q1 2023, Q1 2022, and Q1 2021 respectively.